ACT-1004-1239

Product Specifications

CAS Number

2178049-58-4

Target

CXCR

Related Pathways

Immunology/Inflammation|||GPCR/G Protein|||Autophagy

Purity

0.9831

Bioactivity

ACT-1004-1239 is an orally active, selective, and potent CXCR7 antagonist with immune-modulatory and myelin-promoting effects. It can be used to study inflammatory demyelinating diseases.

Smiles

N(C(=O)[C@@H]1[C@@H](NC(=O)C=2C=C(ON2)C3=C(F)C=C(F)C=C3)CCN(CC4CC4)C1)C5(CC5)C=6N=CC=CN6

Molecular Formula

C27H28F2N6O3

Molecular Weight

522.55

Shipping Conditions

Cool pack

Storage Temperature

-20°C

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

NBP2-72348PEATT594 0.1 mL

Mouse Monoclonal ARL11 Antibody (OTI1A5) [PE/Atto594]

Ask

View Details

B2018547 1 mg

22-NBD 25-hydroxycholesterol

Ask

View Details

PVT78161 2 µg

PLV3-U6-WASHC1-sgRNA2-Cas9-Hyg Plasmid

Ask

View Details

GTR15313872 1 Vial

Lentiviral human DNAJC8 shRNA (UAS) - Lentiviral human DNAJC8 shRNA (UAS, GFP) (100)

Ask

View Details

abx922607-01 15 nmol

Human LINC00846 siRNA

Ask

View Details

abx922607-02 30 nmol

Human LINC00846 siRNA

Ask

View Details